Why Dynavax Technologies Stock Is Sinking Today
Published
A lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.
Full ArticlePublished
A lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.
Full ArticleA COVID-19 vaccine candidate that employs the company's adjuvant technology produced positive clinical trial results.